Renal, Electrolyte and Hypertension Division, Department of Medicine, Philadelphia, PA, USA.
Atherosclerosis. 2010 Oct;212(2):589-94. doi: 10.1016/j.atherosclerosis.2010.05.016. Epub 2010 May 19.
Coronary artery calcification (CAC) predicts cardiovascular events in the general population. We conducted a prospective study to determine if inflammatory markers were predictive of CAC and if CAC predicted cardiovascular events and mortality in incident renal transplant recipients.
A prospective cohort of 112 asymptomatic incident renal transplant recipients who had no prior history of coronary artery revascularization or myocardial infarction had coronary calcifications measured early post-transplant and at least 18 months later by Agatston score and volume method.
The mean CAC score was 367.7 (682.3). Inflammatory markers such as WBC and CRP were predictive of CAC severity. Recipients with cardiovascular events (n=11) or death (n=12) during the follow-up period had higher mean [675.1 (669.3) vs. 296.8 (669.0), p=0.02] and median [434.8 vs. 28.9, p=0.01] CAC score compared to those without them. Recipients with CAC score less than 100 had a better cumulative survival rate compared to the recipients with CAC score greater than 100 [95.1% vs. 82.3%, p=0.03]. We found a significant unadjusted and adjusted association between CAC score and cardiovascular events and mortality. A quarter (25.9%) of recipients had CAC progression. Coronary calcification progression also predicted cardiovascular events and mortality after adjustment for diabetes and dialysis vintage.
CAC is prevalent in renal recipients and is predictive of cardiovascular events and mortality. Coronary calcification progression is common and predict clinical outcomes. Inflammatory markers are predictive of CAC severity at time of transplant, but are not predictive of future cardiovascular event or mortality.
冠状动脉钙化(CAC)可预测普通人群中的心血管事件。我们进行了一项前瞻性研究,以确定炎症标志物是否可预测 CAC,以及 CAC 是否可预测初发肾移植受者的心血管事件和死亡率。
对 112 例无症状初发肾移植受者进行前瞻性队列研究,这些受者在移植前没有冠状动脉血运重建或心肌梗死病史,在移植后早期和至少 18 个月后通过 Agatston 评分和体积法测量 CAC。
CAC 评分的平均值为 367.7(682.3)。白细胞和 CRP 等炎症标志物可预测 CAC 的严重程度。在随访期间发生心血管事件(n=11)或死亡(n=12)的受者,其平均[675.1(669.3)比 296.8(669.0),p=0.02]和中位数[434.8 比 28.9,p=0.01]CAC 评分均高于无事件者。CAC 评分低于 100 的受者累积生存率优于 CAC 评分大于 100 的受者[95.1%比 82.3%,p=0.03]。我们发现 CAC 评分与心血管事件和死亡率之间存在显著的未调整和调整后关联。四分之一(25.9%)的受者发生 CAC 进展。在调整糖尿病和透析年限后,冠状动脉钙化进展也可预测心血管事件和死亡率。
CAC 在肾移植受者中很常见,可预测心血管事件和死亡率。冠状动脉钙化进展很常见,可预测临床结局。炎症标志物可预测移植时 CAC 的严重程度,但不能预测未来的心血管事件或死亡率。